| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,948,284 |
|
|
Indirect Shares
|
60,990,264 |
|
|
| Direct
Value |
$199,176,147 |
|
|
|
Indirect Value
|
$173,068,344 |
|
|
| Total
Shares |
88,938,548 |
|
|
| Total
Value |
$372,244,491 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
95
|
|
Stock
price went up :
|
14
|
1
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,834.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-19 |
1,566,956 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-01-23 |
7,594 |
2024-01-23 |
6,955,191 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2023-08-23 |
30,707,722 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
630 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VMSI |
Ventana Medical Systems I... |
Director |
– • – |
2008-02-08 |
4 |
D |
$89.50 |
$251,028,347 |
D/D |
(2,804,786) |
0 |
0 |
- |
|
| VMSI |
Ventana Medical Systems I... |
Director |
– • – |
2008-02-08 |
4 |
D |
$89.50 |
$39,476,123 |
I/I |
(441,074) |
0 |
0 |
- |
|
| VMSI |
Ventana Medical Systems I... |
Director |
– • – |
2008-02-11 |
4 |
D |
$89.50 |
$1,118,750 |
I/I |
(12,500) |
0 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2013-03-06 |
4 |
D |
$0.00 |
$0 |
I/I |
(27,428,840) |
0 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-01-23 |
4 |
GD |
$0.00 |
$0 |
I/I |
689,355 |
0 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2008-03-06 |
4 |
B |
$15.45 |
$188,490 |
I/I |
12,200 |
4,067 |
2.1 |
- |
|
| BIOL |
Biolase Inc |
10% Owner |
– – • |
2015-10-12 |
4 |
B |
$1.03 |
$118,244 |
I/I |
114,800 |
14,800 |
1.5 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-12-14 |
4 |
S |
$2.58 |
$55,470 |
I/I |
(21,500) |
21,500 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2013-06-13 |
4 |
S |
$105.75 |
$200,073 |
I/I |
(1,892) |
27,110 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2012-11-09 |
5 |
GD |
$0.00 |
$0 |
I/I |
16,300 |
29,340 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
|
• • • |
2022-12-09 |
4 |
S |
$0.91 |
$9,100 |
I/I |
(10,000) |
36,595 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2008-03-07 |
4 |
B |
$14.62 |
$964,920 |
I/I |
66,000 |
37,066 |
2.1 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2008-03-07 |
4 |
B |
$14.62 |
$482,460 |
I/I |
33,000 |
37,067 |
2.1 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
|
• • • |
2022-12-08 |
4 |
S |
$0.93 |
$9,300 |
I/I |
(10,000) |
46,595 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-06-05 |
4 |
B |
$9.08 |
$499,173 |
I/I |
54,975 |
54,975 |
2.25 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
|
• • • |
2022-12-07 |
4 |
S |
$0.96 |
$9,600 |
I/I |
(10,000) |
56,595 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
|
• • • |
2022-12-06 |
4 |
S |
$0.99 |
$9,900 |
I/I |
(10,000) |
66,595 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2023-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
75,949 |
75,949 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
|
• • • |
2022-12-05 |
4 |
S |
$0.97 |
$9,700 |
I/I |
(10,000) |
76,595 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
|
• • • |
2022-12-02 |
4 |
S |
$1.00 |
$10,000 |
I/I |
(10,000) |
86,595 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2008-03-10 |
4 |
B |
$14.03 |
$2,197,098 |
I/I |
156,600 |
89,267 |
2.1 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
|
• • • |
2022-12-01 |
4 |
S |
$1.03 |
$10,300 |
I/I |
(10,000) |
96,595 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
|
• • • |
2022-11-30 |
4 |
S |
$0.99 |
$9,900 |
I/I |
(10,000) |
106,595 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-03-21 |
4 |
B |
$2.32 |
$258,275 |
I/I |
111,407 |
111,407 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
|
• • • |
2022-11-29 |
4 |
S |
$1.01 |
$10,100 |
I/I |
(10,000) |
116,595 |
0 |
- |
|
630 Records found
|
|
Page 1 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
